Lataa...
Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
Patients with non-small-cell lung cancer (NSCLC) whose tumours harbour activating mutations within the epidermal growth factor receptor (EGFR) frequently derive significant clinical and radiographic benefits from treatment with EGFR tyrosine kinase inhibitors (TKIs). As such, prospective identificat...
Tallennettuna:
| Julkaisussa: | Ann Oncol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6454547/ https://ncbi.nlm.nih.gov/pubmed/29462254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx703 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|